Fidelity Investments’s Fortress Biotech FBIO Stock Holding History
Bought
Maintained
Sold
Other funds holding FBIO
OM
GCP
SAM
BCM
Fidelity Investments's FBIO Position: Q2 2026 in Review
Fidelity Investments sold out of Fortress Biotech (FBIO) in Q2 2026, closing a stake of 220 shares — an estimated $614 sold.
Fidelity Investments first reported a position in FBIO in Q2 2013 and held it in 17 quarters. The position peaked at $35.3M in Q3 2013. 55 funds tracked by Wall St. Rank hold FBIO as of Q2 2026.
- Fidelity Investments reported no remaining Fortress Biotech position as of Q2 2026 after selling out during the quarter.
- Fidelity Investments sold 220 Fortress Biotech shares in Q2 2026, an estimated $614.
- Fidelity Investments first reported a position in Fortress Biotech in Q2 2013 and held it in 17 quarters.
- Fidelity Investments's Fortress Biotech position peaked at $35.3M in Q3 2013.
- 55 funds tracked by Wall St. Rank held Fortress Biotech as of Q2 2026.
Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.